MarginsXMarginsX
Home › Markets › Health Care › MPLT

MapLight Therapeutics Inc. (MPLT)

MPLT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.90
-4.83% on the day
Market cap
$446.9M
Small cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMPLT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2025
SEC CIK0001770069
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Recent IPO: no annual report filed yet.

Warning signs

Cash runway
4.9 months
$71.6M cash at June 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed August 13, 2026
Insider net buying, 12 months
$145.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-13
Cash and burn$71.6M cash; operating cash flow -$43.7M a quarter.Report 2026-06-30
Shares outstanding46,377,832 (2026-07-31).Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorRSM US LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-04-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $174.9M, sold $29.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$60.2M-$44.9M$71.6MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$60.7M-$51.2M$55.7MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$79.5M-$46.8M$46.7MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$29.4M-$31.8M$64.1MNo debt tagsNeeds four quarters10-Q 2025-12-04
Q2 2025
2025-06-30
Not filed-$29.8M-$34.0MNot filedNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$22.3M-$25.6MNot filedNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$21.2M-$21.5M$38.3MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2024
2024-09-30
Not filed-$19.0MNot filedNot filedNo debt tagsNeeds four quarters10-Q 2025-12-04

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-11-16
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 216 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.6%
1 month-7.9%
3 months-37.4%
Year to date-58.7%
1 year-49.2%
From 52-week high-81.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
DMACDiaMedica Therapeutics Inc.$8.33-5.23%$449.5M
ARVNArvinas Inc.$6.77-0.73%$443.3M
OVIDOvid Therapeutics Inc.$2.40-5.51%$453.0M
EOLSEvolus Inc.$6.63-4.74%$438.8M
ASMBAssembly Biosciences Inc.$21.29+0.80%$436.0M
BLSMBlossomHill Therapeutics Inc.$13.65-2.64%$433.9M
CTMXCytomX Therapeutics Inc.$1.99-2.70%$432.7M
KMDAKamada Ltd.$8.11+0.25%$468.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier